March 2022 - Page 2 of 13 - NetworkNewsWire

WednesdayMar 30, 2022 9:00 am

Friendable Inc. (FDBL) Announces Initial Launch and Release of Newly Acquired FeaturedX; Brings 360 Artist Offering Full Circle

FeaturedX Co-founders Ryan “Tuck” O’Leary and Jeff Menig will stay on in their roles Robert A. Rositano Jr., CEO of Friendable, marks the acquisition and retention of the co-founders to be a step forward in the pursuit of offering the ultimate 360 artist offering – focusing on revenue, artists, and additional services In 2022, Friendable has seen remarkable growth for its Fan Pass Live platform, with over 111,000 artists now available and social media trending upward Friendable (OTC: FDBL), a mobile technology and marketing company, has announced the initial launch and release of FeaturedX.com – a web-property acquired in January…

WednesdayMar 30, 2022 9:00 am

Silo Pharma Inc. (SILO) Is ‘One to Watch’

Silo recently extended its option with the University of Maryland, Baltimore to explore arthritogenic joint-homing peptides and their use in arthritis-inflamed joints In December 2021, the company announced the issuance of a patent relating to its University of Maryland, Baltimore licensed homing peptide for enhanced targeting of therapeutic agents to the central nervous system The company signed an agreement with Columbia University granting it an option to license certain assets currently under development, including an Alzheimer’s disease formulation targeting NDMARs and 5-HT4Rs, as well as a prophylactic treatment for stress-induced disorders and PTSD Silo currently has under review four U.S.…

TuesdayMar 29, 2022 9:15 am

American Cannabis Partners Strong Contender as Opportunities to Market Products Increase

“Between government regulations and rigid policies from Big Tech, marketing cannabis will keep you on your toes,” HID article observes Article forecasts more brands will move to platforms that have cannabis-friendly community guidelines ACP positioning itself in four sectors of cannabis space: real estate, cultivation, medical research and nonprofit groups As the cannabis landscape continues to shift, with growing numbers of states allowing some form of the substance and federal legislation examining changes in legal status, cannabis companies such as American Cannabis Partners (“ACP”) will see increasing opportunities to market their products. “Between government regulations and rigid policies from Big…

TuesdayMar 29, 2022 9:15 am

Sneak Peek at NobleCon18’s Current Lineup of Keynotes & Moderators

Designed to merge ideas with investment, NobleCon18 (the first full in-person NobleCon since February 2020) will feature 100+ carefully selected emerging growth public companies. With total attendance limited to 1,000, this ideal-sized event will provide investors with more direct access to executive teams over the course of the two-day conference. Taking place at The Guitar Hotel near Miami on April 20 and 21, the conference agenda will feature multiple presentation tracks, hundreds of scheduled meetings and breakouts, engaging panel discussions offering varied insights on a range of relevant topics, and unlimited opportunities for networking. Here is the latest list of…

TuesdayMar 29, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Provides Update on Advances in Brain Cancer Drugs and Operational Financials

Texas-based CNS Pharmaceuticals is a novel brain cancer drug developer that is building a series of global clinical trials for its lead drug candidate, Berubicin CNS began dosing patients in a global trial last September to evaluate Berubicin in treating glioblastoma multiforme (“GBM”), currently an incurable brain cancer CNS received FDA Fast Track designation for Berubicin in June 2021 and FDA Orphan Drug designation for Berubicin in June 2020 Berubicin is a novel anthracycline capable of crossing the blood-brain barrier The company received approval from Switzerland’s swissethics organization for Berubicin trials there, boosting CNS’s efforts at a global response to…

TuesdayMar 29, 2022 9:00 am

Correlate Infrastructure Partners Inc. (CIPI) Is ‘One to Watch’

CIPI closed on acquisitions of subsidiaries Correlate and Solar Site Design on December 28, 2021 The company has filed with the SEC to change its name to Correlate Infrastructure Partners Inc. CIPI subsidiaries have a project pipeline of over $100 million, with more than $20 million in awarded backlog The company’s total addressable market is more than 5.9 million commercial buildings in U.S., representing a market value of $290 billion in 2022 Correlate Infrastructure Partners (OTCQB: CIPI), formerly Triccar Inc., through its two subsidiaries, Correlate and Solar Site Design, offers a complete suite of proprietary clean energy assessment and fulfilment…

TuesdayMar 29, 2022 9:00 am

Smarter Homes, Smarter Cars, Smarter People

NetworkNewsWire Editorial Coverage: The Internet of Things (“IoT”) has evolved over the last couple decades, weaving its way into daily life by providing increased utility and functionality for everyday items. Broadly speaking, IoT refers to the overarching technology that connects physical items (e.g., refrigerators, door locks, HVAC) to the internet so they can be controlled from a mobile or desktop app to provide real-time controls and data analysis. Delivering convenience and savings, many of these interconnected devices have become readily available and affordable with an estimated 46 billion connected devices in the world today. That may sound like a lot,…

TuesdayMar 29, 2022 9:00 am

Hero Technologies Inc. (HENC) CEO Talks ‘Foot in the Door’ Acquisitions in Recent Bell2Bell Podcast

HENC is focusing on expansion of current operations, future growth in industry Company aims to be a low-cost, nationally and internationally branded company, become true multistate operator (“MSO”) Recent podcast provides overview of company’s strategic plans, important milestones Key acquisitions and investments have played an essential role in Hero Technologies’ (OTC: HENC) strategic business plan and operations. As a featured guest during a recent episode of the Bell2Bell Podcast (https://nnw.fm/LUcyo), company CEO Gina Serkasevich discussed HENC’s careful expansion moves. In 2020, “both Highly Relaxing and the assets of V Brokers, under Veteran Hemp Co., were acquired,” said Serkasevich as she discussed…

MondayMar 28, 2022 9:15 am

Kronos Advanced Technologies Inc. (OTC: KNOS) Air Purifier Features Most Effective Technology Available

Air purifiers can improve indoor air quality, help soothe allergy and asthma symptoms, and rid air of toxins. Kronos’s proprietary, medical-grade technology has been tested as the most effective clean-air solution on the market. An air purifier “may be the household investment to make this year” (“USA Today”) The global pandemic has drawn attention to the fact that airborne particles can be dangerous, even life threatening. Kronos Advanced Technologies (OTC: KNOS) has developed one of the most effective air purifiers available today. One study attributed over two million deaths annually to indoor air pollution (https://nnw.fm/afMbo). Air purifiers are part of…

MondayMar 28, 2022 9:15 am

DGE’s 2nd Real World Evidence and Market Access Symposium to Access High Quality Data to Meet the Patient Needs

Life science executives are invited to attend the 2nd Real World Evidence and Market Access Symposium being held as a virtual event on April 11-12, 2022. The event is hosted by DGE, a leading global event management company that caters to the dynamic informational and networking needs of the pharmaceutical, biotechnology, health care, medical devices, and allied industries. The event centers around discussions, keynotes and sessions about the latest advances and best practices for harnessing real-world data insights that are productive for patients, payers and providers. Organizations can strengthen their business and reimbursement strategies by identifying and accessing the correct…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Month: March 2022

Friendable Inc. (FDBL) Announces Initial Launch and Release of Newly Acquired FeaturedX; Brings 360 Artist Offering Full Circle

Silo Pharma Inc. (SILO) Is ‘One to Watch’

American Cannabis Partners Strong Contender as Opportunities to Market Products Increase

Sneak Peek at NobleCon18’s Current Lineup of Keynotes & Moderators

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Provides Update on Advances in Brain Cancer Drugs and Operational Financials

Correlate Infrastructure Partners Inc. (CIPI) Is ‘One to Watch’

Smarter Homes, Smarter Cars, Smarter People

Hero Technologies Inc. (HENC) CEO Talks ‘Foot in the Door’ Acquisitions in Recent Bell2Bell Podcast

Kronos Advanced Technologies Inc. (OTC: KNOS) Air Purifier Features Most Effective Technology Available

DGE’s 2nd Real World Evidence and Market Access Symposium to Access High Quality Data to Meet the Patient Needs

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsWire Currently Accepts

Company Search

Site Search